Compare GENB & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GENB | NOMD |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Packaged Foods |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | N/A | 2015 |
| Metric | GENB | NOMD |
|---|---|---|
| Price | $12.90 | $9.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $23.20 | $12.75 |
| AVG Volume (30 Days) | 321.2K | ★ 1.2M |
| Earning Date | 05-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.45 | $1.45 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.00 | $9.43 |
| 52 Week High | $14.21 | $20.13 |
| Indicator | GENB | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 33.71 |
| Support Level | $11.32 | $9.49 |
| Resistance Level | $13.69 | $12.36 |
| Average True Range (ATR) | 1.16 | 0.24 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 57.88 | 15.25 |
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.